1
0
0
ProgrammeEURETINA
euretina.org
Dr. Ulrike Graefe-Mody Global Head Retinal Health. BOEHRINGER INGELHEIM. Mr. Paul Hallen VP Global Head Retina & Glaucoma. ALCON. Dr. Naama Hammel
ZEISS und Boehringer Ingelheim geben Zusammenarbeit ...Zeiss
www.zeiss.com
— Ulrike Graefe-Mody. Head of Retinal Health bei Boehringer Ingelheim. Seit über 100 Jahren ist ZEISS ein Pionier der Optik. Die Expertise auf — Ulrike Graefe-Mody. Head of Retinal Health bei Boehringer Ingelheim. Seit über 100 Jahren ist ZEISS ein Pionier der Optik. Die Expertise auf ...
ZEISS, Boehringer Ingelheim partner to early detect and ...NS Medical Devices
www.nsmedicaldevices.com
— Boehringer Ingelheim retinal health head Ulrike Graefe-Mody said: “Our partnership with ZEISS will allow us to develop precision therapies — Boehringer Ingelheim retinal health head Ulrike Graefe-Mody said: “Our partnership with ZEISS will allow us to develop precision therapies ...
Zeiss and Boehringer Ingelheim Collaborate to Enable ...Vision Monday
www.visionmonday.com
— ... Ulrike Graefe-Mody, PhD, head of retinal health at Boehringer Ingelheim. MORE ON: BUSINESS. Medevise Consulting Achieves ISO — ... Ulrike Graefe-Mody, PhD, head of retinal health at Boehringer Ingelheim. MORE ON: BUSINESS. Medevise Consulting Achieves ISO
LinkedIn: Ulrike Graefe-Mody - Boehringer Ingelheimlinkedin.com
› posts › ulrike-graefe-mody
LinkedIn: Beitrag von Ulrike Graefe-Mody - World Sight Day - LinkedIn
› posts › ulrike-graefe-mody
LinkedIn: Ulrike Graefe-Mody | Berufsprofil - LinkedIn
Ulrike Graefe-Modys berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Ulrike Graefe-Mody dabei hilft, interne Kontakte zu finden, die mit empfohlenen Kandidaten, Branchenexperten und potenziellen Geschäftspartnern verbunden sind.
Ulrike Graefe-Mody | LinkedInwww.linkedin.com › ulrike-graefe-mody-5574b114b
www.linkedin.com
View articles by Ulrike Graefe-Mody ; What can we learn from others? Exploring… September 29, likes1 comment ; Accelerating Innovation through ...
Boehringer Ingelheim and ZEISS join forces to early detect ...Business Wire
www.businesswire.com
— ... Ulrike Graefe-Mody, Ph.D., Head of Retinal Health at Boehringer Ingelheim. As a leading pioneer of science in optics for more than 100 years — ... Ulrike Graefe-Mody, Ph.D., Head of Retinal Health at Boehringer Ingelheim. As a leading pioneer of science in optics for more than 100 years ...
Dr. Ulrike Gräfe-Mody über Work-Life-Balance und DiversityBoehringer Ingelheim
www.boehringer-ingelheim.com
Dr. Ulrike Gräfe-Mody erzählt von ihrem Werdegang, der immer wieder von Diversity geprägt war. Außerdem teilt sie einen privaten Einblick in ihr Modell der Work ...
Work-Life-Balance und Diversity | Boehringer Ingelheim
www.boehringer-ingelheim.com
WEBFrauen in Führung: Dr. Ulrike Gräfe-Mody über Work-Life-Balance und Diversity. Dr. Ulrike Gräfe-Mody erzählt von ihrem Werdegang, der immer wieder von Diversity geprägt war. …
Ask A MannheimerMannheim Business School
www.mannheim-business-school.com
Ulrike Graefe-Mody, inspiring leader and expert in healthcare at Boehringer Ingelheim in the latest issue of Ask a Mannheimer. Rimm Elfu | Mannheim EMBA Class ...
Eva Ulrike Gräfe-Mody | 1 Publications | 181 CitationsAI Chat for scientific PDFs
typeset.io
Eva Ulrike Gräfe-Mody is an academic researcher. The author has contributed to research in topics: Pharmacokinetics & Metabolite. Eva Ulrike Gräfe-Mody is an academic researcher. The author has contributed to research in topics: Pharmacokinetics & Metabolite.
Effect of Multiple Oral Doses of Linagliptin on the Steady-State ...
libgen.ggfwzs.net
Dr Christian Friedrich, Andreas Port, Arne Ring, Ulrike Graefe-Mody, Thomas Giessmann, Mario Iovino, Hans-Juergen Woerle. How much do you like this book? › dfaebf
RSC AdvancesRSC Publishing
pubs.rsc.org
von NK Nannapaneni · · Zitiert von: 14 — Ulrike Graefe-Mody, Thomas Giessmann, Arne Ring, Mario Iovino, and Hans-. Juergen Woerle, A randomized, open-label, crossover study evaluating the effect of. von NK Nannapaneni · · Zitiert von: 14 — Ulrike Graefe-Mody, Thomas Giessmann, Arne Ring, Mario Iovino, and Hans-. Juergen Woerle, A randomized, open-label, crossover study evaluating the effect of.
Grempler Rolf | 8 Publications | 54 Citations | Related Authors
typeset.io
Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics. [...] Eva Ulrike Graefe-Mody 1, ... › authors
The DPP‐4 inhibitor linagliptin does not prolong the QT ...John Wiley
bpspubs.onlinelibrary.wiley.com
von A Ring · · Zitiert von: 39 — E. Ulrike Graefe-Mody,. E. Ulrike Graefe-Mody. Boehringer Ingelheim Pharma GmbH & Co. KGIngelheim.
Comparable pharmacodynamics, efficacy, and safety of ...
www.scienceopen.com
Author(s): Akiko Sarashina Christian Friedrich , Susanne Crowe , Sanjay Patel , Ulrike Graefe‐Mody , Naoyuki Hayashi , Yoshiharu Horie. Author(s): Silke Retlich , Vincent Duval , Arne Ring , Alexander Staab , Silke Hüttner , Arvid Jungnik , Ulrich Jaehde , Klaus A Dugi , Ulrike Graefe-Mody. › do...
Comparable pharmacodynamics, efficacy, and safety of linagliptin 5 mg...
www.deepdyve.com
... Ulrike Graefe-Mody , Naoyuki Hayashi , Yoshiharu Horie 1 2 Clinical Pharmacokinetics/Pharmacodynamics Department, Nippon Boehringer ...
Linagliptin, a Potent and Selective DPP-4 Inhibitor, Is Safe and...
professional.diabetes.org
BARBARA UHLIG-LASKE, ARNE RING, ULRIKE GRAEFE-MODY, CHRISTIAN FRIEDRICH, KIRSTEN HERBACH, HANS-JUERGEN WOERLE, KLAUS A. DUGI ...
Safety, tolerability, pharmacokinetics and pharmacodynamics ...Clinical Diabetes and Endocrinology
clindiabetesendo.biomedcentral.com
von S Bianzano · · Zitiert von: 11 — Ulrike Gräfe-Mody. Show authors. Clinical Diabetes and Endocrinology ... Susanna Bianzano & Ulrike Gräfe-Mody. Profil, Neuss, Germany. Tim ...
Ulrike Graefe-Mody – ScienceOpen
www.scienceopen.com
Authors: Heike Zimdahl, Carina Ittrich, Ulrike Graefe-Mody … Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and ...
A reference map of potential determinants for the human ...Archive ouverte HAL
hal.science
... Ulrike Graefe-Mody , Patrick Baum , Rolf Grempler , Cecilia Engel Thomas , Federico De Masi , Caroline Anna Brorsson , Gianluca Mazzoni , Rosa Allesøe Ulrike Graefe-Mody , Patrick Baum , Rolf Grempler , Cecilia Engel Thomas , Federico De Masi , Caroline Anna Brorsson , Gianluca Mazzoni , Rosa Allesøe ...
Drug Metabolism and PharmacokineticsJ-Stage
www.jstage.jst.go.jp
Ulrike GRAEFE-MODY, Peter ROSE, Arne RING, Kerstin ZANDER, Mario IOVIN ... Article type: Regular Article Volume 26 Issue 2 Pages Published ...
ZEISS and Boehringer Ingelheim aim to change YouTubeYouTube · ZEISS Medical Technology (International)480+ Aufrufe · vor 6 Monaten
www.youtube.com
ZEISS's Euan S. Thomson, Ph.D., President of Ophthalmology & Head of Digital Business, and Ulrike Graefe-Mody, Ph.D., Head of Retinal Health ...
„Modelle mit geteilten Verantwortlichkeiten können erfolgreich ...careers.boehringer-ingelheim.com › blog › post › mod...
careers.boehringer-ingelheim.com
Ulrike Gräfe-Mody vorstellen, Associate Head of Medicine, Metabolism bei Boehringer Ingelheim. Ein Beitrag von Taiseer Kuzbari und Sarah ...
My vision for 2030? Change vision! | by Ulrike Graefe-Mody | LinkedInwww.linkedin.com › pulse › my-vision chang...
www.linkedin.com
· So, that is my long-term vision, what is yours? Published By. Ulrike Graefe-Mody ...
What do you hope for in retinal health? | by Ulrike Graefe-Mody ...www.linkedin.com › pulse › what-do-you-hope-reti...
www.linkedin.com
· More from Ulrike Graefe-Mody ... My vision for 2030? Change vision! April 6,
A start-up within an established company - the best of both worlds?www.linkedin.com › pulse › start-up-within-establis...
www.linkedin.com
Ulrike Graefe-Mody. Published Mar 29, + Follow. Unbelievably, it has been just over a year since we started working remotely. However, even during a ...
My vision for 2030? Change vision! - LinkedInwww.linkedin.com › pulse › my-vision chang...
www.linkedin.com
Ulrike Graefe-Mody. Published Apr 6, + Follow. Did you ever realize that the eyes give us approximately 80 percent of the information about what ...
What do you hope for in retinal health? - LinkedInwww.linkedin.com › pulse › what-do-you-hope-reti...
www.linkedin.com
Ulrike Graefe-Mody. Published Oct 8, + Follow. What does 'hope' mean to you? To me, hope is a word that stimulates optimism and expectation and is a ...
Ulrike Graefe-Mody | LinkedIn
www.linkedin.com
View Ulrike Graefe-Mody's full profile. It's free! Your colleagues, classmates, and 500 million other professionals are on LinkedIn. View Ulrike's Full Profile ...
Ulrike Graefe-Mody on LinkedIn: Investing in our peoplelinkedin.com
www.linkedin.com
View profile for Ulrike Graefe-Mody. Ulrike Graefe-Mody. 1y Edited. Report ... Ulrike Graefe-Mody, Head of Retinal Health at Boehringer Ingelheim. View profile for Ulrike Graefe-Mody. Ulrike Graefe-Mody. 1y Edited. Report ... Ulrike Graefe-Mody, Head of Retinal Health at Boehringer Ingelheim.
Ulrike Graefe-Mody on LinkedIn: PostDoc grant | Retinopathylinkedin.com
www.linkedin.com
Ulrike Graefe-Mody's Post ... Exciting opportunity to work with our incredible retinal diseases research team that continues to deliver innovative approaches to ... Ulrike Graefe-Mody's Post ... Exciting opportunity to work with our incredible retinal diseases research team that continues to deliver innovative approaches to ...
Ulrike Graefe-Mody on LinkedIn: Transforming Science Daylinkedin.com
www.linkedin.com
View profile for Ulrike Graefe-Mody · Ulrike Graefe-Mody. 6mo. Report this ... Ulrike Graefe-Mody, Head of Retinal Health at Boehringer Ingelheim. View profile for Ulrike Graefe-Mody · Ulrike Graefe-Mody. 6mo. Report this ... Ulrike Graefe-Mody, Head of Retinal Health at Boehringer Ingelheim.
Ulrike Graefe-Mody's Postlinkedin.com
www.linkedin.com
Congratulations Ulrike Graefe-Mody! Like · Reply. 1 Reaction. See more ... Ulrike Graefe-Mody, Head of Retinal Health at Boehringer Ingelheim. We ... Congratulations Ulrike Graefe-Mody! Like · Reply. 1 Reaction. See more ... Ulrike Graefe-Mody, Head of Retinal Health at Boehringer Ingelheim. We ...
www.linkedin.com › postsUlrike Graefe-Mody on LinkedIn: Just returning from an inspiring day ...
www.linkedin.com
Ulrike Graefe-Mody on LinkedIn: Just returning from an inspiring day ...
Ulrike Graefe-Mody's Postlinkedin.com
www.linkedin.com
Ulrike Graefe-Mody's Post ... Exciting opportunity for an experienced competitive intelligence manager with background in retina, to work closely with the ... Ulrike Graefe-Mody's Post ... Exciting opportunity for an experienced competitive intelligence manager with background in retina, to work closely with the ...
Ulrike Graefe-Mody's Postlinkedin.com
www.linkedin.com
View profile for Ulrike Graefe-Mody. Ulrike Graefe-Mody. 5mo. Report this ... Ulrike Graefe-Mody, Head of Retinal Health at Boehringer Ingelheim. View profile for Ulrike Graefe-Mody. Ulrike Graefe-Mody. 5mo. Report this ... Ulrike Graefe-Mody, Head of Retinal Health at Boehringer Ingelheim.
What can we learn from others? Exploring collaborations in ...
www.linkedin.com
Ulrike Graefe-Mody. Published Sep 29, + Follow. Retinal conditions have widespread and profound implications for many aspects of life, health, ... › pulse
Treatment for diabetes in patients with insufficient glycemic ...
patents.google.com
Application number: US ,196; Inventor: Eva Ulrike Graefe-Mody: Thomas Klein: Michael Mark: Hans-Juergen Woerle; Current Assignee (The listed assignees ... › patent
US A1 - Treatment for diabetes in patients ...
patents.google.com
Application number: US ,295; Other versions: US B2 (en; Inventor: Klaus Dugi: Eva Ulrike Graefe-Mody: Ruth Harper: Hans-Juergen Woerle ... › patent
Boehringer Ingelheim and ZEISS join forces to early detect ...Yahoo Finance
finance.yahoo.com
— ... Ulrike Graefe-Mody, Ph.D., Head of Retinal Health at Boehringer Ingelheim. As a leading pioneer of science in optics for more than 100 years ...
Eva Ulrike Graefe-Mody - Entity | RPX Insight
insight.rpxcorp.com
Eva Ulrike Graefe-Mody has 0 patent litigation cases (0 cases currently active) - 0 patents asserted - 0 cases as a plaintiff - 0 cases as a defendant.
Boehringer Ingelheim and ZEISS join European Businesseuropean-biz.com
www.european-biz.com
... Ulrike Graefe-Mody, Ph.D., Head of Retinal Health at Boehringer Ingelheim. As a leading pioneer of science in optics for more than 100 years, ZEISS's ...
Alle Infos zum Namen "Ulrike Gräfe"
Verwandte Suchanfragen zu Ulrike Gräfe
| Gerd Starrach Matthias Starrach Markus Veit | Susanne Bauer-Vollmer |
Person "Gräfe" (8) Vorname "Ulrike" (34734) Name "Gräfe" (787) |
sortiert nach Relevanz / Datum